seed
Stage
2021
Founded
1
Investors
About
Preimure develops a biocompatible coating technology designed to reduce implant-related infections, particularly in artificial joints, by releasing antibiotics long after surgery and acting as a barrier against bacterial colonization.
Explore Preimure's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.